PEGylated analogue of an IGF-1 splice-variant fragment called mechano growth factor
PRODUCT PROFILE
PEG-MGF
£61.00
PEG-MGF is pegylated analogue of an igf-1 splice-variant fragment called mechano growth factor. Researchers examine it in relation to muscle loading, satellite-cell and tissue-repair hypotheses.
Why it is distinct
A modified splice-variant fragment rather than a direct full IGF-1 receptor analogue.
- Evidence stageExperimental
- AvailabilityUnavailable
- Batch recordOpen COA
- DispatchConfirmed at checkout
Out of stock
Ask about availabilitySUGGESTED ADD-ONS
Useful additions, clearly shown.
Suggestions are organised by vial format and catalogue context. They are not combined-use guidance or personal-use advice.
-
Specification review
Bacteriostatic Water
Price range: £4.49 through £8.9910 mL | 3 mLBatch file pendingA laboratory supply with two volume variants, not a peptide or biologically active comparison material.
Available · select size for stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Preclinical
BPC-157
£32.99Batch COA availableBPC-157 is mainly discussed around stomach and local tissue-repair models. TB-500 is instead studied for actin, cell movement…
Available · 30 in stockAdd to basket -
Preclinical
TB-500
£32.99Batch COA availableTB-500 is discussed as a fragment-like repair material, while thymosin beta-4 is the full natural protein and BPC-157…
Available · 30 in stockAdd to basket
PRODUCT INFORMATION
Clear first. Detailed when needed.
What this material is+
PEG-MGF is pegylated analogue of an igf-1 splice-variant fragment called mechano growth factor. Researchers examine it in relation to muscle loading, satellite-cell and tissue-repair hypotheses.
Research focus+
Researchers study whether it can influence repair signals and muscle stem cells after mechanical stress. Claims about muscle growth are not supported by robust human trials.
How the mechanism differs+
PEGylation is intended to prolong exposure to an MGF-related peptide fragment; product sequence and chemistry vary between suppliers.
Evidence and limitations+
Predominantly preclinical with very limited validation of commercial PEG-MGF materials and no established human outcomes.
Testing and batch documentation+
Verified batch documents are available for review.
RESEARCH PROFILE
Understand the distinction.
Researchers study whether it can influence repair signals and muscle stem cells after mechanical stress. Claims about muscle growth are not supported by robust human trials.
PEGylation is intended to prolong exposure to an MGF-related peptide fragment; product sequence and chemistry vary between suppliers.
A modified splice-variant fragment rather than a direct full IGF-1 receptor analogue.
Predominantly preclinical with very limited validation of commercial PEG-MGF materials and no established human outcomes.
Educational research context only. This information is not dosage, administration or personal-use guidance.
CONTINUE EXPLORING
Related research perspectives.
Selected for useful comparison across neighbouring or contrasting research areas—not as combined-use guidance.
-
Early human evidence
CJC-1295 No DAC
Price range: £25.99 through £32.995 mgBatch COA availableShort-duration GHRH signalling, in contrast with albumin-bound, long-acting CJC-1295 DAC.
UnavailableAsk about availability This product has multiple variants. The options may be chosen on the product page -
Established
Sermorelin
£49.005 mgBatch COA availableClosest to the natural active GHRH sequence and shorter acting than tesamorelin or CJC-1295 DAC.
UnavailableAsk about availability -
Early human evidence
GHRP-2
£44.005 mgBatch COA availableTypically characterised as a strong GH secretagogue with less appetite emphasis than GHRP-6.
UnavailableAsk about availability -
Established clinical evidence
Tesamorelin
£52.99Batch COA availableIt is the GHRH analogue in this catalogue with an authorised indication and outcome trials for a defined…
Available · 50 in stockAdd to basket